- Latest available (Revised)
- Original (As made)
There are outstanding changes not yet made by the legislation.gov.uk editorial team to Medicines (Products for Animal Use—Fees) (Amendment No. 2) Regulations 2001. Any changes that have already been made by the team appear in the content and are referenced with annotations.
Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.
Regulation 2
Column (1) | Column (2) | Column (3) | Column (4) |
---|---|---|---|
Provision in the principal Regulations | Subject matter | Old fee | New fee |
£ | £ | ||
Regulation 12 | Manufacturer’s licences: annual fees | 205 | 210 |
Regulation 13 | Wholesale dealer’s licences: annual fees | ||
Regulation 13(1) | Turnover of £40,000 or more | 410 | 420 |
Regulation 13(2) | Turnover of less than £40,000 | 205 | 210 |
Regulation 14 | Registration of Homoeopathic Veterinary Medicinal Products | ||
Regulation 14(3) | Alteration of dossier | 90 | 95 |
SCHEDULE 1, PART II | FEES RELATING TO APPLICATIONS FOR THE GRANT OF MARKETING AUTHORISATIONS, PRODUCT LICENCES, MANUFACTURER’S LICENCES, WHOLESALE DEALER’S LICENCES AND ANIMAL TEST CERTIFICATES | ||
Paragraph 1, Table A, Column (2) | Fee for an application for a type A marketing authorisation | ||
Entry 1 | Major application | 19,595 | 20,085 |
Entry 2 | Complex application | 11,370 | 11,655 |
Entry 3 | Standard application | 4,910 | 5,035 |
Entry 4 | Abridged standard application | 3,835 | 3,930 |
Entry 5 | Simple application | 1,385 | 1,400 |
Paragraph 1, Table A, Column (3) | Fee for an application for a type B marketing authorisation | ||
Entry 1 | Major application | 10,815 | 11,085 |
Entry 2 | Complex application | 6,490 | 6,655 |
Entry 3 | Standard application | 3,245 | 3,325 |
Entry 5 | Simple application | 865 | 885 |
Paragraph 1, Table A, Column (4) | Fee for an application for a product licence | ||
Entry 1 | Major application | 19,595 | 20,085 |
Entry 2 | Complex application | 11,370 | 11,655 |
Entry 3 | Standard application | 4,910 | 5,035 |
Entry 5 | Simple application | 1,365 | 1,400 |
Paragraph 2, Table B, Column (2) | Fee for an application for an Article 15.2 marketing authorisation | ||
Entry 1 | Major application | 11,370 | 11,655 |
Entry 2 | Complex application | 4,910 | 5,035 |
Paragraph 3 | Application for a marketing authorisation by holder of Article 15.2 marketing authorisation | ||
Paragraph 3(a) | Major application previously made | 8,225 | 8,430 |
Paragraph 3(b) | Complex application previously made | 6,460 | 6,620 |
Paragraph 6 | Manufacturer’s licences | ||
Paragraph 6(1)(b) | Other cases | 2,205 | 2,260 |
Paragraph 7 | Wholesale dealer’s licences | ||
Paragraph 7(1) | Application fee where anticipated turnover £40,000 or more | 1,280 | 1,310 |
Paragraph 7(2) | Application fee where anticipated turnover less than £40,000 | 520 | 535 |
Paragraph 8 | Animal test certificate applications in relation to biological products or for administration to non food-producing animals | 270 | 275 |
Paragraph 8 | Other animal test certificate applications | 650 | 665 |
Paragraph 9 | Marketing authorisation (parallel import) | 1,530 | 1,570 |
SCHEDULE 1, PART III | FEES RELATING TO APPLICATIONS FOR ASSISTANCE IN CONNECTION WITH MUTUAL RECOGNITION APPLICATIONS | ||
Paragraph 4, Table C, Column (2) | Basic fee | ||
Entry 1 | Major | 3,515 | 3,605 |
Entry 2 | Complex | 2,350 | 2,410 |
Entry 3 | Standard | 1,015 | 1,040 |
Entry 4 | Simple | 340 | 350 |
Paragraph 4, Table C, Column (3) | Additional fee for the sixth and each additional member State | ||
Entry 1 | Major | 760 | 780 |
Entry 2 | Complex | 370 | 380 |
Entry 3 | Standard | 190 | 195 |
Paragraph 5, Table D, Column (2) | Basic Fee | ||
Entry 1 | Category I application | 8,625 | 8,840 |
Entry 2 | Category II application | 5,755 | 5,900 |
Entry 3 | Category III application | 4,600 | 4,715 |
Paragraph 5, Table D, Column (3) | Additional fee for the sixth and each additional member State | ||
Entry 1 | Category I application | 1,080 | 1,105 |
Entry 2 | Category II application | 720 | 740 |
Entry 3 | Category III application | 575 | 590 |
SCHEDULE 1, PART IV | FEES RELATING TO APPLICATIONS FOR THE VARIATION OF MARKETING AUTHORISATIONS, PRODUCT LICENCES, MANUFACTURER’S LICENCES, WHOLESALE DEALER’S LICENCES AND ANIMAL TEST CERTIFICATES | ||
Paragraph 3, Table F, Column (2) | United Kingdom acting as the Reference Member State | ||
Entry 1 | Type I variation—Administrative | 575 | 590 |
Entry 2 | Type I variation—Scientific | 2,300 | 2,360 |
Entry 3 | Type 1 variation, Scientific—Type II procedure | 3,785 | 3,880 |
Entry 4 | Type II variation | 8,050 | 8,250 |
Entry 5 | Variation with extras | 9,205 | 9,435 |
Paragraph 3, Table F, Column (3) | United Kingdom not acting as the Reference Member State | ||
Entry 1 | Type I variation—Administrative | 110 | 115 |
Entry 2 | Type I variation—Scientific | 545 | 560 |
Entry 3 | Type I variation, Scientific—Type II procedure | 1,080 | 1,105 |
Entry 4 | Type II variation | 2,165 | 2,220 |
Entry 5 | Variation with extras | 3,850 | 3,945 |
Paragraph 5 | Manufacturer’s licences | ||
Paragraph 5(b) | Variation in any other case | ||
Paragraph 5(b)(i) | Requiring assessment | 390 | 400 |
Paragraph 5(b)(ii) | Not requiring assessment | 130 | 135 |
Paragraph 6 | Wholesale dealer’s licences | ||
Paragraph 6(a) | Variation requiring assessment | 390 | 400 |
Paragraph 6(b) | Variation not requiring assessment | 130 | 135 |
Paragraph 7 | Variation of animal test certificate | 215 | 220 |
SCHEDULE 1, PART V | FEES RELATING TO APPLICATIONS FOR THE RENEWAL OF MARKETING AUTHORISATIONS, PRODUCT LICENCES, MANUFACTURER’S LICENCES AND ANIMAL TEST CERTIFICATES | ||
Paragraph 1 | Marketing authorisations and product licences | ||
Paragraph 1(b) | Herbal products | 325 | 335 |
Paragraph 1(c) | Other cases | 975 | 1,000 |
Paragraph 2 | Manufacturer’s licences | 95 | 100 |
Paragraph 3 | Animal test certificates | 95 | 100 |
SCHEDULE 2 | FEES RELATING TO SITE INSPECTIONS | ||
Paragraph 2(1), Table A, Column (2) | |||
Entry 1 | Supersite inspection | 9,070 | 9,295 |
Entry 2 | Major inspection | 4,770 | 4,890 |
Entry 3 | Standard inspection | 3,415 | 3,500 |
Entry 4 | Minor inspection | 1,845 | 1,890 |
Paragraph 2(2), Table B, Column (2) | |||
Entry 1 | Supersite inspection | 15,035 | 15,410 |
Entry 2 | Major inspection | 8,305 | 8,515 |
Entry 3 | Standard inspection covering immunological Veterinary Medicinal Products | 5,420 | 5,555 |
Entry 4 | Other standard inspection | 4,085 | 4,185 |
Entry 5 | Minor inspection covering immunological Veterinary Medicinal Products | 2,730 | 2,800 |
Entry 6 | Other minor inspection | 2,730 | 2,800 |
Paragraph 2(3), Table C, Column (2) | |||
Entry 1 | Supersite inspection | 6,585 | 6,750 |
Entry 2 | Major inspection | 4,450 | 4,560 |
Entry 3 | Standard inspection | 2,180 | 2,235 |
Entry 4 | Minor inspection | 1,125 | 1,155 |
Paragraph 3(1) | Either or both of premises and procedures for quality control of a biological product which is not a dormant product | 1,305 | 1,335 |
SCHEDULE 5, PART II | FEES RELATING TO APPLICATIONS FOR REGISTRATION OF HOMOEOPATHIC VETERINARY MEDICINAL PRODUCTS | ||
Paragraph 1, Table, Column (2) | Fees for applications in respect of products prepared from not more than 5 homoeopathic stocks | ||
Entry 1 | Product both prepared solely from repeat stock and being of repeat formulation | 110 | 115 |
Entry 2 | Product which is either prepared solely from repeat stock or is of a repeat formulation | 325 | 335 |
Entry 3 | Any other application | 545 | 560 |
Paragraph 1, Table, Column (3) | Fees for applications in respect of products prepared from more than 5 homoeopathic stocks | ||
Entry 1 | Product both prepared solely from repeat stock and being of repeat formulation | 270 | 275 |
Entry 2 | Product which is either prepared solely from repeat stock or is of a repeat formulation | 485 | 495 |
Entry 3 | Any other application | 700 | 720 |
Paragraph 2 | Equivalent product registered under Part II of the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994 or in an EEA State | ||
Paragraph 2 (i) | Product prepared from not more than 5 homoeopathic stocks | 110 | 115 |
Paragraph 2(ii) | Product prepared from more than 5 homoeopathic stocks | 270 | 275 |
SCHEDULE 6 | MARKETING AUTHORISATIONS, PRODUCT LICENCES AND ANIMAL TEST CERTIFICATES: FEES FOR REFERENCES TO THE VETERINARY PRODUCTS COMMITTEE OR TO THE MEDICINES COMMISSION | ||
Paragraph 1, Table, Column (2) | |||
Entry 1 | Major application | 1,540 | 1,580 |
Entry 2 | Complex application | 885 | 905 |
Entry 3 | Standard application | 410 | 420 |
Entry 4 | Simple application | 155 | 160 |
Paragraph 2 | Animal test certificate | 535 | 550 |
1. The application fee for a minor variation (Type 1) to a marketing authorisation (other than a mutually recognised marketing authorisation) as referred to in Annex 1 to Commission Regulation (EC) No. 541/95 (concerning the examination of variations to the terms of a marketing authorisation granted by a competent authority of a member State M1) shall be as follows:—U.K.
Fee | ||
---|---|---|
Type of application | £ | |
1. | Change following modification(s) to the manufacturing authorisation | 560 |
2. | Change in the name of the medicinal product (either invented name or common name) | 560 |
3. | Change in the name and/or address of the marketing authorisation holder | 220 |
4. | Replacement of an excipient with a comparable excipient (excluding adjuvants for vaccines and biologically derived excipients) | 560 |
5. | Change in the colouring system of the product (addition, deletion or replacement of colourant(s)) | 560 |
6. | Change in the flavouring system of the product (addition, deletion or replacement of flavour(s)) | 560 |
7. | Change in coating weight of tablets or change in weight of capsule shells | 560 |
8. | Change in the qualitative composition of immediate packaging material | 560 |
9. | Deletion of an indication | 560 |
10. | Deletion of a route of administration | 560 |
10a. | Addition or replacement of measuring device for dosage forms | 560 |
11. | Change in the manufacturer(s) of active substance | 560 |
11a. | Change in name of manufacturer of active substance | 220 |
11b. | Change in supplier of intermediate compound used in the manufacture of the active substance | 560 |
12 | Minor change of manufacturing process of the active substance | 560 |
12a. | Change in specification of starting material or intermediate used in the manufacture of the active substance | 560 |
13. | Batch size of active substance | 560 |
14. | Change in specification of active substance | 560 |
15. | Minor change in manufacture of the medicinal product | 560 |
15a. | Change in in-process controls applied during the manufacture of the product | 560 |
16. | Change in the batch size of finished product | 560 |
17. | Change in specification of the medicinal product | 560 |
18. | Synthesis or recovery of non-pharmacopoeial excipients which had been described in the original dossier | 560 |
19. | Change in specification of excipients in the medicinal product (excluding adjuvants for vaccines) | 560 |
20. | Extension of shelf life as foreseen at time of authorisation | 560 |
20a. | Extension of the shelf life or retest period of the active substance | 560 |
21. | Change in shelf life after first opening | 560 |
22. | Change in shelf life after reconstitution | 560 |
23. | Change in the storage conditions | 560 |
24. | Change in test procedure of active substance | 560 |
24a. | Change in test procedure for a starting material or intermediate used in the manufacture of the active substance | 560 |
25. | Change in the test procedures of the medicinal product | 560 |
26. | Changes to comply with supplements to pharmacopoeias | 560 |
27. | Change in test procedures of non-pharmacopoeial excipients | 560 |
28. | Change in test procedure of immediate packaging | 560 |
29. | Change in test procedure of administrative device | 560 |
30. | Change in pack size for a medicinal product | 560 |
31. | Change in container shape | 560 |
32. | Change of imprints, bossing or other markings (except scoring) on tablets or printing on capsules, including addition or changes of inks used for product marking | 560 |
33. | Change of dimensions of tablets, capsules, suppositories or pessaries without change of quantitive composition and mean mass | 560 |
34. | Change in the manufacturing process of a non proteinaceous component due to the subsequent introduction of a biotechnology step | 560 |
Marginal Citations
M1OJ No. L55, 11.3.95, p. 7 as last amended by Commission Regulation (EC) No. 1146/98, OJ No. L159, 3.6.98, p.31.
2. The application fee for any other variation to a marketing authorisation (other than a mutually recognised marketing authorisation), or for any variation to a product licence, shall be £2,220 except in the following cases, where the fee shall be the amount specified:—U.K.
Fee | ||
---|---|---|
Type of application | £ | |
a. | Change which is made where there is identical supporting data relating to another product which is also being changed, all the products are from the same marketing authorisation holder and the change is identical to the first change and is made at the same time | 220 |
b. | Change of distributor where no other aspects of the dossier are changed and the marketing authorisation holder remains the same | 220 |
c. | Change of marketing authorisation holder where no other aspects of the dossier are changed | 220 |
d. | Simple dosage instruction changes where the change is not the result of safety concerns, no new studies are required to support the change and the dose rate in mg/kg body weight remains the same | 560 |
e. | Addition or change to user safety warnings where no other aspects of the dossier are changed, no user safety warnings are removed, no new studies are required to support the change and the proposed warnings serve to increase the protection of the user | 560 |
f. | Corrections or simple text lay out changes to summary of product characteristics and/or product literature where the changes are not a result of safety concerns, no new studies are required to support the change and no other aspects of the dossier are changed | 560 |
2A. Notwithstanding the above, the fee for a variation where the licence relates solely to an emergency vaccine shall be £40 for each variation.U.K.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: